Showing 4181-4190 of 5957 results for "".
- LKC Technologies Releases Consensus Document for Managing Diabetic Retinopathy in Optometryhttps://modernod.com/news/lkc-technologies-releases-consensus-document-for-managing-diabetic-retinopathy-in-optometry/2481825/LKC Technologies, a provider of functional testing using electroretinography (ERG), released "Modern Fundamentals of Diabetic Retinopathy Management in Optometry," a new report on diabetic retinopathy (DR) developed by an
- Eye Care Charity Orbis Announces New Partnership with Heidelberg Engineeringhttps://modernod.com/news/eye-care-charity-orbis-announces-new-partnership-with-heidelberg-engineering/2481817/Orbis announced a new partnership with Heidelberg Engineering in which Heidelburg will fund crucial teaching opportunities and research—focusing on training eye care professionals around the world via Cybersight (Orbis’s telemedicine and e-learning p
- Alcon to Showcase New Data and Innovation to Support Ophthalmic Surgical Teams at ESCRShttps://modernod.com/news/alcon-to-showcase-new-data-and-innovation-to-support-ophthalmic-surgical-teams-at-escrs/2481815/Alcon will present a lineup of scientific data at the 41st Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) Sept. 8-12 in Vienna, Austria. Alcon will showcase product updates designed to deliver patient outcomes and operational efficiencies for ophthalmologists an
- BVI Expands its Presence in Spain and Portugal Acquiring Medical Mixhttps://modernod.com/news/bvi-expands-its-presence-in-spain-and-portugal-acquiring-medical-mix/2481813/BVI announced it has acquired Medical Mix, an ophthalmic medical device supplier in Spain and Portugal. Financial terms of the deal were not disclosed. BVI said its European footprint with direct sales representatives and infrastructure now spans all major western Eu
- CooperVision to Spotlight Myopia Control and Management Advocacy at ESCRShttps://modernod.com/news/coopervision-to-spotlight-myopia-control-and-management-advocacy-at-escrs/2481809/CooperVision will spotlight advancing myopia control and management as standard of care across all ocular health sectors at the 2023 European Society of Cataract and Refractive Surgeons (ESCRS) conference in Vienna. On September 7, a thought leadership panel will be held
- Rayner Unveils Enhancements to Digital Platforms at ESCRS 2023https://modernod.com/news/rayner-unveils-enhancements-to-digital-platforms-at-escrs-2023/2481808/Rayner has announced a series of updates to its digital platforms, RayPRO and Peer2Peer, designed to redefine patient-reported outcome measures (PROMs) and elevate clinical ophthalmic education. Attendees of the ESCRS 2023 congress are invited to explore these advancements at Booth B303
- EyeSouth Partners Affiliates with Retina and Vitreous of Texashttps://modernod.com/news/eyesouth-partners-affiliates-with-retina-and-vitreous-of-texas/2481807/EyeSouth Partners has announced that it has partnered with Retina and Vitreous of Texas (RVT), in Houston. The affiliation represents EyeSouth’s 38th overall and the network’s first retina-only affiliation in the state of Texas. Financial terms of the deal were not disclosed
- OcuCell Secures Funding from The Eye-Bank for Sight Restorationhttps://modernod.com/news/ocucell-secures-funding-from-the-eye-bank-for-sight-restoration/2481804/Ocular cell therapy company OcuCell announced it has received seed funding from The Eye-Bank for Sight Restoration (EBSR). The funding will enable OcuCell to accelerate its mission of transforming the corneal cell therapy landscape through the development of cell therapy solut
- Sydnexis Appoints Nick Ruth Chief as Commercial Officerhttps://modernod.com/news/sydnexis-appoints-nick-ruth-chief-as-commercial-officer/2481799/Sydnexis has announced the appointment of industry veteran Nick Ruth, MBA, as its Chief Commercial Officer (COO). Mr. Ruth will lead Sydnexis’ commercial strategy and transition from a clinical based organization to both a clinical and commercial based organization. With
- Zeiss Surpasses 8 Million Eyes Treated with SMILE Worldwidehttps://modernod.com/news/zeiss-surpasses-8-million-eyes-treated-with-smile-worldwide/2481789/Zeiss announced that more than 8 million eyes have been treated with Small Incision Lenticule Extraction (SMILE) globally to date. The FDA approved the VisuMax Femtosecond Laser for the SMILE procedure in 2016. “Zeiss SMILE is a game-changer for lase